Clinical Research on Treatment of Climacteric Syndrome by Combination of Yi-Shen Yang-Xin Shu-Gan Decoction and Acupuncture Therapy
10.11842/wst.2014.05.027
- VernacularTitle:益肾养心疏肝汤联合针灸治疗女性更年期综合征的临床研究
- Author:
Ping ZHOU
;
Ouna CHEN
;
Qiong JIANG
;
Ying ZHOU
- Publication Type:Journal Article
- Keywords:
Climacteric syndrome;
Yi-Shen Yang-Xin Shu-G an decoction;
acupuncture;
combine traditional Chinese and western medicine;
clinical effect
- From:
World Science and Technology-Modernization of Traditional Chinese Medicine
2014;(5):1117-1121
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to explore the clinical effect on treatment of climacteric syndrome by the combina-tion of Yi-Shen Yang-Xin Shu-Gan (YSYXSG) decoction and acupuncture therapy. A total of 78 female patients suffering from climacteric syndrome were selected and randomly divided into two groups, with 39 cases in each group. The control group was treated with oral administration of estradiol valerate. The treatment group was treated with the combination of YSYXSG decoction and acupuncture therapy on basis of western medicine treatment. Four-week was one treatment course. The treatment was continued for three treatment courses. Improvement state of both groups were compared by the integration of clinical symptoms before and after treatment as well as the Hamilton's Depression Scale (HAMD)/(HAMA). The results showed that according to the clinical symptoms, both groups had im-provements in varying degrees (P< 0.05, P< 0.01), in which HAMD, HAMA, FSH decreased (P< 0.05), and E2 in-creased (P< 0.05). The treatment group had more obvious superiority compared to the control group. There was sta-tistical significance between two groups (P < 0.05). The total efficiency rate of the treatment group was obviously higher than the control group with statistical significance (P < 0.05). It was concluded that combination of YSYXSG decoction, acupuncture therapy with hormonotherapy had more superiority in improving clinical symptoms, remitting emotion of anxiety-depression and controlling patient's condition compared with pure hormonotherapy, which had su-periority.
